Semaglutide and tirzepatide can lead to significant weight loss in these patients and improve their blood sugar levels, which could reduce their risk of complications of obesity and diabetes, including heart disease and eye, nerve and kidney problems.
Written by FormBlends Medical Content Team Medical content team
That said, knowing how it works and what its limits are will help you use it the right way
Research published in 2024 demonstrates that GLP-1 receptor agonists significantly reduce body weight through multiple mechanisms, with patients experiencing substantial improvements in body composition
The differentiator is pathway-level insight into FTO, GLP1R, and MC4R variants a layer Hims, Fridays, and most telehealth-only programs do not place beside the medication itself
The role of dimethylaminoethanol in cosmetic dermatology. American Journal of Clinical Dermatology , 2005